Skip to content
10-Q

Quarterly Report

Treace Medical Concepts, Inc. TMCI

0001193125-25-269556

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 63.72M sh
Shares Diluted Q3 2025 · Sep 30, 2025 63.52M sh
Shares Diluted Q3 2025 · Sep 30, 2025 63.07M sh
Shares Diluted Q3 2025 · Sep 30, 2024 62.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 62.04M sh
Capex Q3 2025 · Sep 30, 2025 $11.12M
Capex Q3 2025 · Sep 30, 2024 $8.52M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$7.94M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$32.96M
Long Term Debt Q3 2025 · Sep 30, 2025 $53.53M
Long Term Debt Q3 2025 · Dec 31, 2024 $53.31M
Short Term Debt Q3 2025 · Sep 30, 2025 $1.8M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $7.69M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $11.35M
Stockholders Equity Q3 2025 · Sep 30, 2025 $89.19M
Stockholders Equity Q3 2025 · Jun 30, 2025 $97.62M
Stockholders Equity Q3 2025 · Mar 31, 2025 $105.34M
Stockholders Equity Q3 2025 · Dec 31, 2024 $112.89M
Stockholders Equity Q3 2025 · Sep 30, 2024 $104.91M
Stockholders Equity Q3 2025 · Jun 30, 2024 $112.14M
Stockholders Equity Q3 2025 · Mar 31, 2024 $126.39M
Stockholders Equity Q3 2025 · Dec 31, 2023 $137.94M
Current Liabilities Q3 2025 · Sep 30, 2025 $40.91M
Current Liabilities Q3 2025 · Dec 31, 2024 $34.93M
Total Liabilities Q3 2025 · Sep 30, 2025 $107.4M
Total Liabilities Q3 2025 · Dec 31, 2024 $104.2M
Current Assets Q3 2025 · Sep 30, 2025 $138M
Current Assets Q3 2025 · Dec 31, 2024 $161.4M
Total Assets Q3 2025 · Sep 30, 2025 $196.59M
Total Assets Q3 2025 · Dec 31, 2024 $217.09M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.26
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.79
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.25
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.89
Eps Basic Q3 2025 · Sep 30, 2025 −$0.26
Eps Basic Q3 2025 · Sep 30, 2025 −$0.79
Eps Basic Q3 2025 · Sep 30, 2024 −$0.25
Eps Basic Q3 2025 · Sep 30, 2024 −$0.89
Sga Expense Q3 2025 · Sep 30, 2025 $16.28M
Sga Expense Q3 2025 · Sep 30, 2025 $48.22M
Sga Expense Q3 2025 · Sep 30, 2024 $13.53M
Sga Expense Q3 2025 · Sep 30, 2024 $42.11M
Rd Expense Q3 2025 · Sep 30, 2025 $4.68M
Rd Expense Q3 2025 · Sep 30, 2025 $15.74M
Rd Expense Q3 2025 · Sep 30, 2024 $4.96M
Rd Expense Q3 2025 · Sep 30, 2024 $15.38M
Net Income Q3 2025 · Sep 30, 2025 −$16.29M
Net Income Q3 2025 · Sep 30, 2025 −$49.61M
Net Income Q3 2025 · Jun 30, 2025 −$17.4M
Net Income Q3 2025 · Mar 31, 2025 −$15.92M
Net Income Q3 2025 · Sep 30, 2024 −$15.36M
Net Income Q3 2025 · Sep 30, 2024 −$55.24M
Net Income Q3 2025 · Jun 30, 2024 −$21.21M
Net Income Q3 2025 · Mar 31, 2024 −$18.68M
Operating Income Q3 2025 · Sep 30, 2025 −$15.68M
Operating Income Q3 2025 · Sep 30, 2025 −$48.23M
Operating Income Q3 2025 · Sep 30, 2024 −$15.13M
Operating Income Q3 2025 · Sep 30, 2024 −$55.48M
Gross Profit Q3 2025 · Sep 30, 2025 $39.71M
Gross Profit Q3 2025 · Sep 30, 2025 $119.35M
Gross Profit Q3 2025 · Sep 30, 2024 $36.13M
Gross Profit Q3 2025 · Sep 30, 2024 $112.79M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $10.51M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $30.82M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $8.95M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $27.86M
Revenue Q3 2025 · Sep 30, 2025 $50.21M
Revenue Q3 2025 · Sep 30, 2025 $150.17M
Revenue Q3 2025 · Sep 30, 2024 $45.09M
Revenue Q3 2025 · Sep 30, 2024 $140.65M